 PLANO, Texas--BUSINESS WIRE--Reata Pharmaceuticals, Inc. Nasdaq: RETA Reata or the Company, a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs after the market closes on August 9, 2021. Reatas management will host a conference call on August 9, 2021, at 4:30 pm ET. The conference call will be accessible by dialing 866 270-1533 toll-free domestic or 412 317-0797 i 